ABOUT US

At Myeloid, we have applied our extensive knowledge of advanced gene and cell therapies to build novel platform technologies and unleash the power of myeloid cells in cancer.

Our proprietary ATAK™ platform is designed to provide clinical solutions by matching therapeutic modalities to disease conditions, including by using autologous cell therapies, in vivo cell programming using mRNA, RNA-based gene-editing using RetroT™ and multi-targeted biologics.  We have translated the learnings from our backgrounds and our novel platform to create a clinical-stage, mRNA-immunotherapy pipeline focused on breakthrough therapies for cancer and autoimmune diseases.

AdobeStock_18058273 cube_fnl_lo.png

The

Myeloid is powered by the discoveries of our founders – a group of world-leading scientists whose expertise spans oncology, immunology, mRNA biology, cell therapy, synthetic biology, and gene delivery.

 

We’re building a team of talented, driven scientists and other biotech industry experts to turn these discoveries into novel, life-saving treatments for people navigating life with cancer.

 

TEAM

LEADERSHIP
Daniel Getts_web_Silhouette_reallo copy.

Daniel Getts, PhD

Chief Executive Officer, Co-founder Board Director

Daniel Getts_web_Silhouette_reallo copy.

Bruce McCreedy, PhD

Chief Science Officer

Daniel Getts_web_Silhouette_reallo copy.

Darren Braccia

Chief Business Officer

Daniel Getts_web_Silhouette_reallo copy.

Michele Cioffi

Vice President, Clinical

Daniel Getts_web_Silhouette_reallo copy.

Michele Gerber, MD, MPH

Chief Medical Officer

Daniel Getts_web_Silhouette_reallo copy.

Thomas Prod’homme

VP Translational Research

BOARD OF DIRECTORS
Daniel Getts_web_Silhouette_reallo copy.png

Elaine Jones, PhD

Board Director

Daniel Getts_web_Silhouette_reallo copy.png

Stanley Frankel, M.D., FACP

Board Director

Daniel Getts_web_Silhouette_reallo copy.png

Daniel Getts, PhD

Co-founder, Chief Executive Officer, Board Director

Daniel Getts_web_Silhouette_reallo copy.png

Brett Kaplan, M.D.

Board Director

Daniel Getts_web_Silhouette_reallo copy.png

Thomas Cahill, MD, PhD

Co-Founder and President

NewpathLogo_lo.png
ARE_Proprietary_Products_RGB_VentureInve
hatteraslogos-rev_new_400 copy.png
8VC-logo-black.png
INVESTORS

SCIENTIFIC ADVISORY BOARD

Clinical Cell

Therapy Advisors

Immunology, Virology & Myeloid Cell Advisors

 
Daniel Getts_web_Silhouette_reallo copy.png

Ronald Vale, PhD

Founder

Daniel Getts_web_Silhouette_reallo copy.png

Yuxiao Wang, PhD

Co-founder and Snr. Director, Discovery Research

Daniel Getts_web_Silhouette_reallo copy.png

Siddhartha Mukherjee, MD, DPhil

Founder & Chair of Advisory Board

Daniel Getts_web_Silhouette_reallo copy.png

Thomas Cahill, MD, PhD

Co-Founder and President

Daniel Getts_web_Silhouette_reallo copy.png

Daniel Getts, PhD

Chief Executive Officer, Co-founder Board Director

FOUNDERS